HUSS RALF has a total of 13 patent applications. Its first patent ever was published in 1998. It filed its patents most often in United States, Canada and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals and biotechnology are IDOGEN AB, ALEXION PHARMA INTERNAT SARL and KOMIPHARM INT CO LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 4 | |
#2 | Canada | 3 | |
#3 | WIPO (World Intellectual Property Organization) | 2 | |
#4 | Australia | 1 | |
#5 | Germany | 1 | |
#6 | EPO (European Patent Office) | 1 | |
#7 | Israel | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Microorganisms | |
#4 | Peptides |
# | Name | Total Patents |
---|---|---|
#1 | Huss Ralf | 12 |
#2 | Nelson Peter Jon | 3 |
#3 | Raggi Matthias C | 3 |
#4 | Nelson Peter C | 2 |
#5 | Nelson Peter J | 2 |
#6 | Stangl Manfred J | 2 |
#7 | Stangl Sr Manfred J | 1 |
Publication | Filing date | Title |
---|---|---|
DE19833476A1 | Genetically modified CD34 negatives, adherently growing hematopoietic stem cells and their use in gene therapy |